The effect is much less with histamine type-2 blockers, such as cimetidine (Tagamet) or famotidine (Pepcid). There can still ...

Targeting both patients and physicians with information about deprescribing proton pump inhibitors may be more effective than communicating with physicians alone.

Since their development and widespread adoption in the late 1980s, proton pump inhibitors (PPI) have transformed the field of gastroenterology. Their high efficacy and favorable safety profiles have ...

"The finding of no association may offer relief for patients who need long-term proton pump inhibitor therapy in the treatment of gastroesophageal reflux disease or for other clear indications." ...

Patient- and physician-facing interventions together doubled the reductions in PPI use ...

Use of proton pump inhibitors appears to increase the risk for kidney failure among patients with CKD. Use of proton pump inhibitors (PPIs) may spur progression to kidney failure in patients with ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: I am a retired male over 65 and a former occasional cigar ...

TOKYO, Jun 2, 2025 - (JCN Newswire) - - Eisai Co., Ltd. announced today the launch of "Pariet S" (pharmaceutical requiring guidance), which is highly effective in alleviating severe heartburn ...

The long term use of proton pump inhibitors (PPIs), a class of drugs widely used to treat acid reflux and ulcers, may not be linked to any increased risk of developing gastric (stomach) cancer, finds ...